Rani Therapeutics Holdings (RANI) Free Cash Flow (2020 - 2026)

Rani Therapeutics Holdings' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$6.5 million for Q1 2026.

• On a quarterly basis, Free Cash Flow rose 20.59% year-over-year to -$6.5 million in Q1 2026; TTM through Mar 2026 was -$17.1 million, a 50.46% increase from a year earlier, with the FY2025 full-year figure at -$18.8 million, up 47.43% from the prior year.
• Free Cash Flow slipped to -$6.5 million in Q1 2026 per RANI's latest filing, from $286000.0 in the prior quarter.
• Across five years, Free Cash Flow topped out at $286000.0 in Q4 2025 and bottomed at -$15.2 million in Q4 2022.
• The 5-year median for Free Cash Flow is -$9.4 million (2024), against an average of -$9.4 million.
• Across the five-year window, Free Cash Flow tumbled 134.15% in 2022 and surged 103.29% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at -$15.2 million in 2022, then gained by 19.22% to -$12.2 million in 2023, then gained by 29.07% to -$8.7 million in 2024, then jumped by 103.29% to $286000.0 in 2025, then tumbled by 2376.92% to -$6.5 million in 2026.
• Per Business Quant, the three latest RANI Free Cash Flow figures stand at -$6.5 million (Q1 2026), $286000.0 (Q4 2025), and -$5.1 million (Q3 2025).